Insmed
INSM
102 hedge funds and large institutions have $539M invested in Insmed in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 22 closing their positions.
147% more call options, than puts
Call options by funds: $4.84M | Put options by funds: $1.96M
43% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 28
1% less funds holding
Funds holding: 103 → 102 (-1)
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
13% less capital invested
Capital invested by funds: $619M → $539M (-$80.6M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$44.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$28.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.1M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$18.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$18.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$17.3M |
| 3 |
O
OrbiMed
New York
|
-$10.8M |
| 4 |
Millennium Management
New York
|
-$7.61M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$7.53M |
INSM Hedge Fund Activity: Q3 2014 in Review
102 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2014, worth a combined $539M — down 13% from $619M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of INSM and 21 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 40 added.
The largest buyer was Palo Alto Investors, adding an estimated $44.2M. The largest seller was Perceptive Advisors, cutting an estimated $18.1M.
- 102 institutional investors held Insmed (INSM) as of Q3 2014, down from 103 in Q2 2014.
- Funds reported $539M of Insmed stock for Q3 2014, down 13% quarter-over-quarter.
- 21 funds opened new Insmed positions in Q3 2014 and 22 closed out, a net change of -1 holder.
- The largest Insmed buyer in Q3 2014 was Palo Alto Investors, an estimated $44.2M added.
- The largest Insmed seller in Q3 2014 was Perceptive Advisors, an estimated $18.1M sold.
Based on aggregated 13F filings for Q3 2014.